Provided by Tiger Trade Technology Pte. Ltd.

Perspective Therapeutics

3.17
-0.1350-4.09%
Volume:118.93K
Turnover:377.77K
Market Cap:360.81M
PE:-2.38
High:3.34
Open:3.32
Low:3.13
Close:3.30
52wk High:6.16
52wk Low:1.96
Shares:114.00M
Float Shares:67.93M
Volume Ratio:1.14
T/O Rate:0.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3300
EPS(LYR):-1.3971
ROE:-39.57%
ROA:-22.28%
PB:1.11
PE(LYR):-2.27

Loading ...

BUZZ-Perspective Therapeutics rises as experimental cancer drug shows promise

Reuters
·
Apr 20

Perspective reports results from Phase 1/2a clinical trial of (212Pb)VMT-alpha-NET

TIPRANKS
·
Apr 20

Perspective Therapeutics reports 43% response rate in [212Pb]VMT-α-NET Phase 1/2a trial

Reuters
·
Apr 20

Perspective Therapeutics Presents Updated Interim Data of [212PB]Vmt-Α-Net in Its Ongoing Phase 1/2a Clinical Trial at the 2026 Aacr Annual Meeting

THOMSON REUTERS
·
Apr 20

Perspective Therapeutics Presents Updated Interim Data of [212Pb]VMT-α-NET in Its Ongoing Phase 1/2a Clinical Trial at the 2026 AACR Annual Meeting

GlobeNewswire
·
Apr 20

Perspective Therapeutics announces annual shareholder meeting

Reuters
·
Apr 17

Perspective Therapeutics to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Apr 02

Perspective Therapeutics Highlights Progress in 212Pb Oncology Pipeline

TIPRANKS
·
Apr 02

Perspective Therapeutics Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 23

Perspective Therapeutics price target raised to $13 from $12 at H.C. Wainwright

TIPRANKS
·
Mar 23

Analysts Are Bullish on Top Healthcare Stocks: Perspective Therapeutics (CATX), Gain Therapeutics (GANX)

TIPRANKS
·
Mar 21

Perspective Therapeutics price target raised to $8 from $7 at UBS

TIPRANKS
·
Mar 19

Perspective Therapeutics Price Target Maintained With a $11.00/Share by Wedbush

Dow Jones
·
Mar 18

B. Riley Raises Price Target on Perspective Therapeutics to $13 From $11, Keeps Buy Rating

MT Newswires Live
·
Mar 18

Analysts Are Bullish on Top Healthcare Stocks: Lantheus (LNTH), Perspective Therapeutics (CATX)

TIPRANKS
·
Mar 18

Perspective Therapeutics to present [212Pb]VMT-α-NET data at AACR Annual Meeting 2026

Reuters
·
Mar 18

Analysts Offer Insights on Healthcare Companies: Perspective Therapeutics (CATX), DocGo (DCGO) and Editas Medicine (EDIT)

TIPRANKS
·
Mar 17

BTIG Reaffirms Their Buy Rating on Perspective Therapeutics (CATX)

TIPRANKS
·
Mar 17

Perspective Therapeutics Price Target Maintained With a $14.00/Share by BTIG

Dow Jones
·
Mar 17

RBC Cuts Price Target on Perspective Therapeutics to $14 From $18, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Mar 17